Skip to content
Thursday23May

Recording / Slides

HIV self-testing (HIVST) is a safe, accurate, and effective alternative to provider-administered testing that many users prefer for its convenience and confidentiality. At IAS 2023, WHO issued a new recommendation to offer HIVST for PrEP initiation and continuation as an innovative way to increase PrEP access and coverage and further simplify PrEP delivery. However, many implementers still have questions on how to effectively roll out and scale up this important self-care intervention. Join AVAC and WHO on 23 May to learn more about WHO guidance on use of HIVST and hear directly from a panel of experts on their experiences rolling out HIVST for PrEP, guidance on procurement and costing, and more.